mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.7 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.7 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.026 |
0.7 |